FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model

Figure 1

FTZ ameliorated the changes in blood glucose, serum insulin, and body weight in diabetic mice. Mice were treated with streptozotocin (STZ) (50 mg/kg/d, injected intraperitoneally every day for 5 consecutive days) followed by treatment with or without FTZ (3 g/kg/d, administrated intragastrically every day for one month). At the end of the experiment, blood glucose (a), body weight (b), and serum insulin (c) were tested. n = 5. , 1, and .

(a)

(b)

(c)